Compare APGE & RITM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APGE | RITM |
|---|---|---|
| Founded | 2022 | 2011 |
| Country | United States | United States |
| Employees | N/A | 6045 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 5.4B |
| IPO Year | 2023 | N/A |
| Metric | APGE | RITM |
|---|---|---|
| Price | $77.78 | $9.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 8 |
| Target Price | ★ $109.25 | $14.56 |
| AVG Volume (30 Days) | 1.0M | ★ 11.6M |
| Earning Date | 03-02-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 10.74% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.52 |
| P/E Ratio | ★ N/A | $10.21 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.20 | $8.43 |
| 52 Week High | $85.04 | $12.74 |
| Indicator | APGE | RITM |
|---|---|---|
| Relative Strength Index (RSI) | 60.14 | 36.37 |
| Support Level | $73.06 | $8.43 |
| Resistance Level | $81.04 | $11.24 |
| Average True Range (ATR) | 4.62 | 0.29 |
| MACD | 0.96 | 0.03 |
| Stochastic Oscillator | 73.26 | 43.48 |
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights), loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.